Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AOBO-001 for Overactive Bladder
NCT01294982Phase 2Completed
- Sponsor
- American Oriental Bioengineering, Inc.
- Start
- Dec 2010
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AOBO-001 in overactive bladder (OAB), sponsored by American Oriental Bioengineering, Inc.. Started Dec 2010; status: completed.
02
Drugs
AOBO-001
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT01294982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01294982.